Objective: Studies have indicated that obesity is associated with a higher risk of colorectal cancer. This study was performed to determine the effect of diet-induced obesity on the formation of azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumors and to identify adiposity-related mechanisms. Methods: Male A/J mice were placed on either a high-fat diet (HFD; 45% of total calories from fat) or a normal diet (ND; 15% of calories from fat) for 12 weeks. To induce colon tumors, AOM was administered at a dose of 10 mg/kg body weight, followed by two cycles of DSS supply. Results: Study results indicated that the HFD group had twofold higher numbers of colonic tumors, as compared with the ND group. The HFD group also had significantly increased body weight and epididymal fat weight, which were associated with increases of serum insulin, insulin-like growth factor-1, leptin, epididymal fat pad leptin mRNA and colonic leptin receptor (Ob-R) mRNA. Animals on HFD showed higher expressions of Ob-R, insulin receptor, phosphorylated Akt, phosphorylated extracellular signal-regulated kinases, Bcl-xL and Cyclin D1 proteins in the colon.
Introduction
Colorectal cancer is one of the most common malignant neoplasms and the third leading cause of cancer death worldwide.
1 Recent epidemiological studies have indicated that overweight and obese people have a higher risk for colon cancer. 2, 3 Colon cancer risk increases by 7% as bodymass index (BMI) increases by 2. 4 However, the mechanisms underlying the relationship between the risk of colon cancer and obesity are not fully understood. Adipose tissue secretes various hormones and growth factors that have a role in colorectal cancer development. 5 Evidence for a positive relationship between circulating insulin concentration and colon cancer risk exists, and a recent meta-analysis showed an increased risk of colorectal cancer with high C-peptide/insulin levels (relative risk ¼ 1.31, 95% confidence interval: 1.13-1.61) in men. 6 Chronically elevated concentrations of insulin decrease insulin-like growth factor-1 binding protein (IGFBP-1) levels, which, in turn, increase the circulating concentration of IGF-1. 7 IGF-1 is a key mitogen required for cell cycle progression to increase the risk of cellular transformation by enhancing cell turnover. 8 However, the relationship between blood IGF-1 concentration and cancer risk has not been clearly demonstrated. Leptin, an adipocyte-derived hormone, is also elevated in obese individuals, 9 and the synthesis of leptin in adipose tissue is influenced by insulin. 10 Despite a lack of direct evidence that increased leptin concentration is a risk factor for colon cancer, studies have proposed that higher leptin concentrations may be a possible link between obesity and colon cancer 11 or colorectal adenoma. 12 In vitro studies have provided evidence that leptin modulates the proliferation of colon adenocarcinoma cells LS174T and HM7. 13 The binding of insulin to its receptor phosphorylates insulin receptor substrates IRS-1 and IRS1/4, stimulating the downstream signaling.
14 IRS-1 activation stimulates the RAS/ RAF/MEK/ERK (extracellular signal-regulated kinase) pathway to induce cell proliferation. The activation of IRS1/ 4-mediated phosphatidylinositol 3-kinase (PI3K)/v-Akt signaling regulates many cellular processes, including cell proliferation, survival, growth and motility processes that are critical for tumorigenesis. [15] [16] [17] Although the link between obesity and colon cancer risk has been suggested based on recent population-based observational studies, as well as in vitro studies, there is limited understanding of the molecular signals induced by excess body fat accumulation in vivo. Therefore, this study investigated the effect of diet-induced obesity on the incidence of azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon carcinogenesis and provided responsible mechanistic explanations. Because excess energy consumption and/or decreased energy expenditure is the most important cause of human obesity, our animal model provided knowledge applicable to prevent obesity-associated colon cancer in humans.
Materials and methods
Mice, chemicals and diets All animal procedures were approved by the Institutional Animal Care and Use Committee of Sookmyung Women's University (SMU-IACUC-2008-1216-001). Four-week-old male A/J mice (SLC Inc., Tokyo, Japan) were used in this study. All animals were housed in plastic cages (with four or five mice/cage) under controlled conditions of humidity (50 ± 10%), light (12-h light/dark cycle) and temperature (23 ± 2 1C). The colon carcinogen AOM was purchased from Sigma Chemical Co. (St Louis, MO, USA). Dextran sodium sulfate, with a molecular weight of 36 000-50 000, was purchased from MP Biochemical, Inc. (Illkirch, France). DSS is known to destroy the mucosal barrier, inducing inflammatory responses and induce colitis. The compositional modifications, based on an AIN-93G, were the following: corn oil and lard, instead of soybean oil, were used as the fat source in the AIN-93G diet (Table 1) . The diets were prepared twice per week and stored in airtight containers in a dark room at 4 1C.
Experimental procedures
Twenty-one male, 4-week-old A/J mice were divided into two groups: a normal-fat diet (ND, n ¼ 10) group and a high-fat diet (HFD, n ¼ 11) group. The mice were acclimated for 1 week with tap water and an ND. At 5 weeks of age, the animals were fed ad libitum either an ND (with 15% of calories coming from fat) or an HFD (with 45% of calories being supplied from fat) for 12 weeks. Animals were administered with a single intraperitoneal injection of AOM (10 mg/kg body weight) at 6 weeks of age. Starting 1 week after the injection, the animals received 2% DSS in their drinking water for two cycles, with each cycle consisting of 7 days. Each cycle was separated by 14 days. Weight gain and food intake were recorded twice per week between 1000 and 1100 hours during the experimental period.
Necropsy and tumor enumeration
All animals were fasted overnight and killed using carbon dioxide. Their colons were removed and rinsed in ice-cold saline. The colons were laid flat on a glass plate, the total number of tumors (nodular, polypoid or caterpillar-like tumors) in the entire colon was enumerated and the entire mucosa was scraped with a glass slide. The epididymal fat pad was immediately collected, rinsed in normal, ice-cold saline and weighed. Blood was collected from the inferior vena cava into EDTA-free tubes and centrifuged at 4000 r.p.m. for 20 min. All samples were stored at À80 1C until the time of assay. Tumor enumeration was performed using a dissecting microscope. The total number of tumors (nodular, polypoid or caterpillar-like tumors) in the entire colon was determined. 
Serum measurements

Reverse-transcription (RT)-PCR
Total RNA was isolated from the epididymal fat pad and colonic mucosa with TRIzol reagent (Life Technologies, Inc., Gaithersburg, MD, USA), according to the manufacturer's instructions. PCR primers were designed using a nucleotide 
Western blot
Frozen colonic mucosa samples from each mouse were homogenized in an ice-cold lysis buffer (Intron, Inc., Seoul, Korea). Homogenates were centrifuged (13 000 r.p.m., 10 min, 4 1C), and the supernatant was collected. The protein content of the lysates was determined using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA). Antibodies to Ob-R (dilution 1:200) and IR (dilution 1:300) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Phospho-Akt (dilution 1:1000), Akt (dilution 1:1000), phospho-ERK (dilution 1:1000), EKR (dilution 1:1000), Bcl-xL (dilution 1:1000) and Cyclin D1 (dilution 1:2000) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-rabbit IgG conjugated with alkaline phosphatase (Cell Signaling Technology) was used as the secondary antibody. All samples were boiled for 5 min and then chilled on ice. Equal quantities (50 mg) of protein were separated by SDS-polyacrylamide gel electrophoresis and transferred onto PVDF membranes (Koma Biotechnology, Seoul, Korea). PVDF membranes were immediately placed in blocking solution (4% non-fat dry milk in TBS-T buffer) for 2 h and incubated with the primary antibody for 2 h followed by the second antibody for 1 h. All incubations occurred at room temperature. Detection of chemiluminescence was performed using enhanced chemiluminescence (ECL) Western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The integrity of the band was quantified by the Versa Doc Quantity One program (Bio-Rad, Mississauga, ON, Canada). All signals were normalized to the levels of b-actin and expressed as ratios.
Statistical analysis
Data were expressed as means ± s.d. Data were analyzed using the Wilcoxon rank sum test. Data were considered to be statistically significant at Po0.05. All analyses were performed using the SAS statistical packages (v. 9.1, SAS Institute, Cary, NC, USA). Figure 2 presents the body weights of AOM/DSS-treated animals fed the ND or HFD. Body weights diverged significantly (Po0.01) between the groups from week 2. At the end of week 12, the HFD group had gained 12.49 ± 2.25 g, as compared with the ND group's gain of 8.57 ± 1.70 g (Po0.01) (Figure 1 ). Epididymal fat weight was higher in the HFD group than in the ND group (Po0.001) (Figures 1a  and b, Table 2 ).
Results
Body and organ weights
Biochemical indices
Serum insulin (Po0.01), IGF-1 (Po0.01) and leptin (Po0.001) concentrations were higher in the HFD group than in the ND group ( Table 2) .
Multiplicity of colonic tumors
We determined the tumor numbers by visually counting them. Figure 2 shows the incidence of tumors in the colon of mice that were fed either NDs or HFDs. The HFD group had 8.36 tumors per mouse, while the ND group had 4.70 tumors per mouse (Po0.01).
Epididymal fat, leptin and colonic mucosa Ob-R mRNA expression Leptin, an adipocyte-derived hormone, is a critical mediator of energy balance; leptin binds to leptin receptors (Ob-R) to exert its physiological effect. Epididymal fat of mice fed HFD showed significantly higher leptin mRNA expression than mice fed ND (Po0.01) (Figure 2 ). In the colonic mucosa, mice fed an HFD had significantly higher Ob-R mRNA expression than those fed an ND (Po0.01).
Levels of Ob-R and IR proteins
Results from the western blot analyses of proteins prepared from the colonic mucosa of mice indicated that HFD significantly upregulated the level of Ob-R (Po0.01) (Figure 3 ).
Levels of p-Akt and p-ERK proteins
Mice fed the HFD had significantly higher p-Akt (Po0.01) and p-ERK (Po0.01) protein levels than those fed an ND (Figure 4 ).
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Levels of Bcl-xL and Cyclin D1 proteins Colonic mucosa of mice fed an HFD had significantly higher levels of anti-apoptotic Bcl-xL (Po0.01) and Cyclin D1, a positive cell cycle regulator (Po0.01) protein, than those fed an ND ( Figure 5 ).
Discussion
In this study, obesity induced by excess energy intake from fat was evaluated as a possible risk factor in colon cancer development. Epidemiological studies have suggested that diet-induced obesity is associated with increased colon cancer risk. [18] [19] [20] [21] Elevated serum levels of insulin and IGF-1 and the increased secretion of adipocyte-derived factors, such as leptin, have been suggested to link obesity to colon carcinogenesis. 13, [22] [23] [24] [25] [26] Because the circulating insulin, IGF-1 and leptin concentrations were closely correlated with the extent of obesity, 2,9,27,28 these factors are presumed to be important Obesity accelerates colon carcinogenesis S-Y Park et al mediators for colon tumor formation. The increased expressions of pro-inflammatory molecules, such as 5-lipoxygenase (5-LOX) protein and LOX-dependent metabolites induced by excess energy intake, are also suggested to be key molecules in colon tumor formation, 29 which indicates that adiposityrelated inflammation may facilitate colon carcinogenesis. In this study, an animal model of colitis-related colorectal cancer was used to investigate the effect of diet-induced obesity on inflammation-related colorectal tumor formation. This model has been used to investigate colorectal cancer development following AOM-induced DNA alteration and DSS-induced inflammation. This model may not represent human sporadic colon cancer where the genetic mutation in APC, a tumor suppressor gene, is frequently involved. 30 
APC
Min/ þ mouse is often used as a mouse model of human sporadic colon cancer.
Our study results showed that average body weights and epididymal fat pad weights were significantly higher in mice fed a HFD, which indicates that fat tissue mass reflects excess energy consumption in this animal model. Increased caloric intake, usually including a HFD, often results in elevated epididymal fat pads, which leads to mouse obesity in many strains of mice that also resembles human obesity. We substituted soybean oil with corn oil because of the possible presence of anticarcinogens such as isoflavones or saponins in soybean oil. Because the proportion of corn oil to lard was maintained the same in both ND and HFD, no change in fatty acid profile was expected. DSS 2% was supplied in combination with AOM (10 mg/kg body weight) to induce colon tumors in A/J mice. An intraperitoneal injection of AOM (10 mg/kg body weight) followed by 1-week exposure to 2% DSS in the drinking water most efficiently induces colonic adenocarcinoma (100% incidence) among various protocols, 31 and this was also observed in this study. DSS has been the most widely used chemical to induce colitis. Carcinogens, such as AOM, have been added to the DSS regimen to facilitate malignant tumors and increase their multiplicity and/or lesion progression. 17, 32 We used the A/J mouse strain to mimic human diet-induced obesity because this strain develops colon tumors using the AOM-DSS protocol, and a previous study indicated that the A/J strain showed a significant increase in circulating leptin concentration when fed a high-fat diet. 33 In our study, obese mice exhibited approximately twofold higher colonic tumor numbers as compared with normal mice, suggesting an excess supply of energy and that the increased adipose tissue is possibly related to the abnormal cell proliferation of the colon tissue in vivo. Recent studies have suggested that obesity facilitates colon tumor formation in adiponectin-gene-deficient mice, 34 APC-genedeficient mice 35 and leptin-gene-deficient mice. 36 However, animal models of specific gene-deficient mice may exhibit different molecular mechanisms for developing tumors from those observed in diet-induced obesity. For example, leptin-gene-deficient mice had significantly higher circulating concentrations of inflammatory cytokines, which Obesity accelerates colon carcinogenesis S-Y Park et al may be related to the colon carcinogenesis without involving leptin, 36 whereas our diet-induced obesity created hyperleptinemia. Therefore, we developed the obese colon cancer model using wild-type animals to study the relationship between diet-induced obesity and colon cancer. Our study results suggested that adipose tissue accumulation may increase the growth of tumors in the colon, which indicated that fat deposition facilitates colon tumor development.
Adipocytes produce and secrete a number of biologically active molecules, and these molecules have a role in stimulating tumor growth. 37, 38 Our study results clearly indicated that obese animals produced significantly higher amounts of insulin, IGF-1 and leptin. These substances are adipocyte-associated molecules and are implicated in cell growth, proliferation, differentiation and cell-cycle control.
The synthesis of leptin in adipocytes is influenced by insulin. 39 Leptin and insulin interact at multiple levels within a network of adipose tissue signaling pathways, providing several mechanisms that could link leptin to cancer. 40 Leptin also modulates the proliferation of colon adenocarcinoma cancer cells LS174T and HM7; this process possibly takes place through Src and PI3K signaling, which is known to promote colon carcinogenesis and metastasis. 41 Other in vitro studies have suggested that these hormones stimulate the PI3K/Akt pathway and induce the phosphorylation of ERK pathways, thus activating these signaltransduction pathways associated with cell growth. 42, 43 The compensatory hyperinsulinemia in obesity also leads to the release of intracellular mediators involved in growth factor signaling, which activate proto-oncogene p21Ras. 44 Growth factor signaling is frequently observed in colon cancer. [45] [46] [47] [48] Animals on a HFD expressed higher levels of colonic leptin mRNA and protein than those eating a diet with a normal amount of fat. IR protein expression was also higher in the colons of the obese HFD animals, although a statistical significance was not found. Tumor cells are resistant to IR downregulation in response to hyperinsulinemia. 49 The mice fed a HFD experienced accelerated colon carcinogenesis possibly through the overexpression of insulin and leptin receptors in response to higher circulating concentrations of respective signaling proteins. The IR is composed of extracellular a-subunits involved in ligand binding and an intracellular b-subunit that transduces the insulin signal to the cell. The localization of IR and Ob-R gene expression throughout the colonic mucosa supports a role for insulin and leptin signaling in regulating cellular processes in this tissue and is pertinent to evidence linking insulin and leptin to colon pathologies. IR and Ob-R act as transcription activators and induce mitogenic effects by initiating the Akt and ERK pathway, which mediate anti-apoptotic and cell cycle progression effects by regulating Bcl-xL and Cyclin D1. 40, 50 In cancer cells, IGF-1 stimulation also induces phosphorylation and activation of Ob-R on Tyr
1141
, and initiates the Akt and ERK pathway. 51 The anti-apoptosis protein, Bcl-xL, a member of the Bcl-2 protein family, may be expressed during the progression of colorectal tumors. 52 The activated Akt molecules regulate cell survival via increase in Bcl-xL activity. 53 Akt also upregulates Cyclin D1 to increase the cell cycle. 54 Cyclin D1 is an important positive regulator of the G1 to S cell cycle transition that is upregulated in AOM-induced colon carcinogenesis. 55 Our study results
showed that obese animals expressed increased levels of p-Akt, p-ERK, Bcl-xL and Cyclin D1 proteins, which correspond to the expectation. Insulin resistance exerts tissue-specific metabolic consequences creating hyperglycemia through decreased glucose uptake in skeletal muscle and adipose tissue, and increased hepatic glucose production. Few studies have reported insulin resistance-mediated changes in glucose or fat metabolism in the colon tissue. We observed increased IR and ObR expression levels, indicating that the increased circulating insulin and leptin levels triggered signaling for accelerated cell growth.
This study investigated the molecular mechanisms involved in obesity-related colorectal cancer development, and is one of a limited number of studies conducted in vivo mimicking human obesity and colon cancer. Study results indicated that hyperinsulinemia and hyperleptinemia induced by a HFD increased the expression of insulin and Obesity accelerates colon carcinogenesis S-Y Park et al leptin receptors in the colonic mucosa and, therefore, it is possible to suggest that receptor-mediated signaling of the PI3K/Akt pathway accelerates abnormal cell growth. However, the AOM-DSS model used in this study does not necessarily reflect human sporadic colon cancer, which is one of the most common types of colon cancer. Further studies on other possible signaling pathways including adiponectin-related cell growth regulation are required to fully understand the relationship between obesity and colon carcinogenesis.
